Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206633 · ClinicalTrials.gov registry record
Hydration Monitor Validation in Elderly
A clinical trial, sponsored by Artann Laboratories.
- Completed
- Registry status
- 73
- Enrollment target
NCT02206633: Completed study, sponsored by Artann Laboratories.
NCT02206633 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02206633 has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The study will aim to determine normal daily variation of the individual hydration level in longitudinal study on elderly in assisted living facility and assess a range of variation of individual hydration baselines for elderly in a normal physiologically hydrated state.
Interventions
- DEVICE Hydration Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-06 |
What the finished NCT02206633 record still lists
NCT02206633 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Hydration Monitor is the first listed.
NCT02206633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02206633 about?
NCT02206633 is a clinical study titled "Hydration Monitor Validation in Elderly". The study will aim to determine normal daily variation of the individual hydration level in longitudinal study on elderly in assisted living facility and assess a range of variation of individual hydration baselines for elderly in a normal physiologically hydrated state.
What is the current status of trial NCT02206633?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2014-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02206633?
The interventions under investigation include: Hydration Monitor (DEVICE).
Who is sponsoring clinical trial NCT02206633?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia